Third Patent Issued for ALASTIN TransFORM

Alastin Issued Third Patient

The U.S. Patent and Trademark Office has issued a third U.S. Patent covering ALASTIN Skincare’s TransFORM Body Treatment. U.S. Patent No. 10,493,011 is entitled, “Peptide Compositions and Methods for Ameliorating Skin Laxity and Body Contour.” The patent is directed to the composition and uses related to TransFORM Body Treatment, both when used alone and when used in conjunction with body-shaping procedures.

“With TransFORM Body Treatment, I am finally able to provide patients with a topical product that perfectly complements invasive and noninvasive fat reduction and body contouring procedures and energy-based body sculpting procedures by accelerating results as well as improving skin tone and crepiness, ensuring patient’s receive ideal post treatment outcomes,” said Laurie Casas, MD, clinical professor of surgery at the University of Chicago Medical Center and owner of Casas Aesthetic Plastic Surgery.

“As we expand the ALASTIN portfolio, our patented TriHex Technology formulations continue to be the building blocks of our ongoing success,” said Diane S. Goostree, CEO of ALASTIN Skincare. “We are proud to be enhancing the outcomes desired by our physician customers and their patients.”